Browsing Tag
Jose C. Clemente
1 post
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
SK Life Science Labs unveiled new AACR 2026 preclinical data on p300 and PRMT5 degraders. Read why this oncology strategy could matter next.